154 related articles for article (PubMed ID: 7501543)
1. Retinoblastoma gene mutations in primary human prostate cancer.
Kubota Y; Fujinami K; Uemura H; Dobashi Y; Miyamoto H; Iwasaki Y; Kitamura H; Shuin T
Prostate; 1995 Dec; 27(6):314-20. PubMed ID: 7501543
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor gene p53 mutations in human prostate cancer.
Kubota Y; Shuin T; Uemura H; Fujinami K; Miyamoto H; Torigoe S; Dobashi Y; Kitamura H; Iwasaki Y; Danenberg K
Prostate; 1995 Jul; 27(1):18-24. PubMed ID: 7603913
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma gene mutations in primary human bladder cancer.
Miyamoto H; Shuin T; Torigoe S; Iwasaki Y; Kubota Y
Br J Cancer; 1995 Apr; 71(4):831-5. PubMed ID: 7710951
[TBL] [Abstract][Full Text] [Related]
4. P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer.
Dahiya R; Deng G; Chen KM; Chui RM; Haughney PC; Narayan P
Br J Cancer; 1996 Jul; 74(2):264-8. PubMed ID: 8688333
[TBL] [Abstract][Full Text] [Related]
5. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the retinoblastoma gene in human prostate adenocarcinoma.
Tricoli JV; Gumerlock PH; Yao JL; Chi SG; D'Souza SA; Nestok BR; deVere White RW
Genes Chromosomes Cancer; 1996 Feb; 15(2):108-14. PubMed ID: 8834174
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer.
Mirchandani D; Zheng J; Miller GJ; Ghosh AK; Shibata DK; Cote RJ; Roy-Burman P
Am J Pathol; 1995 Jul; 147(1):92-101. PubMed ID: 7604888
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors.
Gouyer V; Gazzéri S; Bolon I; Drevet C; Brambilla C; Brambilla E
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):188-96. PubMed ID: 9476905
[TBL] [Abstract][Full Text] [Related]
9. DNA polymerase beta gene mutations in human bladder cancer.
Matsuzaki J; Dobashi Y; Miyamoto H; Ikeda I; Fujinami K; Shuin T; Kubota Y
Mol Carcinog; 1996 Jan; 15(1):38-43. PubMed ID: 8561864
[TBL] [Abstract][Full Text] [Related]
10. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
[TBL] [Abstract][Full Text] [Related]
11. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW
J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408
[TBL] [Abstract][Full Text] [Related]
12. p53 in prostate cancer: frequent expressed transition mutations.
Chi SG; deVere White RW; Meyers FJ; Siders DB; Lee F; Gumerlock PH
J Natl Cancer Inst; 1994 Jun; 86(12):926-33. PubMed ID: 7515114
[TBL] [Abstract][Full Text] [Related]
13. State of adenomatous polyposis coli gene and ras oncogenes in Japanese prostate cancer.
Suzuki H; Aida S; Akimoto S; Igarashi T; Yatani R; Shimazaki J
Jpn J Cancer Res; 1994 Aug; 85(8):847-52. PubMed ID: 7928631
[TBL] [Abstract][Full Text] [Related]
14. Retinoblastoma gene mutation in primary human renal cell carcinoma.
Shuin T; Torigoe S; Kubota Y; Kishida T; Hosaka M; Horikoshi T; Yao M; Kondo K; Sakai N; Danenberg K
Oncol Res; 1995; 7(2):63-6. PubMed ID: 7579728
[TBL] [Abstract][Full Text] [Related]
15. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
Tamboli P; Amin MB; Xu HJ; Linden MD
Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
[TBL] [Abstract][Full Text] [Related]
17. Detection of mutations in the RB1 gene by single strand conformation polymorphism (SSCP) analysis, amplification mismatch detection (AMD) analysis and polymerase chain reaction sequencing.
Dundar M; Lanyon GW; Connor MJ
Proc Natl Sci Counc Repub China B; 2001 Jul; 25(3):166-73. PubMed ID: 11480772
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the retinoblastoma gene in human endometrial carcinoma.
Yaginuma Y; Katayama H; Kawai K; Duenas JC; Ishikawa M
Obstet Gynecol; 1996 May; 87(5 Pt 1):755-9. PubMed ID: 8677081
[TBL] [Abstract][Full Text] [Related]
19. Characterization of intragenic deletions in two sporadic germinal mutation cases of retinoblastoma resulting in abnormal gene expression.
Hashimoto T; Takahashi R; Yandell DW; Xu HJ; Hu SX; Gunnell S; Benedict WF
Oncogene; 1991 Mar; 6(3):463-9. PubMed ID: 2011402
[TBL] [Abstract][Full Text] [Related]
20. The retinoblastoma gene (RB-1) status in multiple myeloma: a report on 35 cases.
Zandecki M; Facon T; Preudhomme C; Vanrumbeke M; Vachee A; Quesnel B; Lai JL; Cosson A; Fenaux P
Leuk Lymphoma; 1995 Aug; 18(5-6):497-503. PubMed ID: 8528059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
